… SARS-CoV-2-positive non-hospitalized adults. We conducted a … patients treated in a COVID-19
virtual outpatient management clinic … of COVID-19 illness in non-hospitalized adults differ …

… , nonhospitalized adults at high risk for progression to severe coronavirus disease 2019 (Covid-19) …
Covid-19–related hospitalization or death from any cause through day 28, viral load, …

… for post-COVID-19 sequelae 27 . This analysis included both hospitalized and non-hospitalized
patients and two control groups consisting of patients without COVID-19 and those with …

… We enrolled nonhospitalized adults who were required to have 4 or fewer days of symptoms
and either PCR-confirmed SARS-CoV-2 infection or compatible symptoms after a high-risk …

… the virus that causes Coronavirus disease 2019 (COVID-19), … treatment of COVID-19 in
non-hospitalized persons 2,3,4,5 . … to moderate COVID-19 in non-hospitalized adults with risk …

… of molnupiravir in nonhospitalized adults with Covid-19, was … Nonhospitalized adults with
mild or moderate Covid-19 were … least one sign or symptom of Covid-19, and at least one risk …

… mild to moderate cases of COVID-19, resulting in a relatively … in COVID-19 patients. Therefore,
we suggested that, similar to nirmatrelvir, high-risk nonhospitalized adults with COVID-19 …

… COVID-19 treatment guidelines suggested remdesivir as an option for high-risk, nonhospitalized
… In a phase 3 trial, 1433 nonhospitalized adults with mild to moderate COVID-19 who …

… COVID-19 infection and SARS-CoV-2 serology test results with persistent physical
symptoms among French adults during the COVID-19 … 2022;182(1):19-25. doi:10.1001/jamainternmed…

… Nirmatrelvir/ritonavir is indicated for the treatment of COVID-19 in adults who do not
require supplemental oxygen and who are at increased risk for progressing to severe …